Literature DB >> 30569163

Effects of menstrual blood‑derived stem cells on endometrial injury repair.

Jia Hu1, Kuangyu Song2, Jing Zhang3, Yiqiong Zhang3, Bu-Zhen Tan1.   

Abstract

The present study aimed to investigate the effects of menstrual blood‑derived stem cells (MenSCs) on endometrial injury repair. MenSCs were isolated from human menstrual blood and were cultured in vitro. Flow cytometric analysis of cells in the third generation demonstrated that MenSCs exhibited higher expression levels of cluster of differentiation (CD)90 and lower expression levels of CD146, which suggested that the MenSCs were cultured successfully. A mechanical damage model of unilateral (right) endometrium was established in BALB/c nude mice, which were divided into four groups, Normal, negative control (NC), Model and MenSC. MenSCs transfected with adenovirus‑enhanced green fluorescent protein were transplanted into the right uterine cavity of mice in the MenSC and NC groups. The protein expression levels of keratin, vimentin, and vascular endothelial growth factor (VEGF) and the average endometrial thickness were measured by immunohistochemistry; the average optical density of vimentin, VEGF and keratin in the MenSC‑treated group was significantly higher compared with the untreated Model group. Fertility tests were performed to determine the pregnancy rate of each group; following endometrial damage in BALB/c nude mice, endometrial thickness was decreased in the Model group, whereas model mice treated with MenSC exhibited increased endometrial thickness and increased the pregnancy rates. Therefore, MenSCs may promote the repair of endometrial lesions in mice by promoting the expression of vimentin, VEGF and keratin.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30569163      PMCID: PMC6323210          DOI: 10.3892/mmr.2018.9744

Source DB:  PubMed          Journal:  Mol Med Rep        ISSN: 1791-2997            Impact factor:   2.952


Introduction

The human uterus is a fibromuscular organ comprising three layers: Endometrium (innermost mucosal layer), myometrium (middle layer) and perimetrium (outer layer) (1). The endometrium is a multi-layered, dynamic organ overlaying the myometrium that is receptive to blastocyst implantation (2). Pregnancy requires effective cooperation between a receptive uterus and a superior blastocyst (3). In cattle and humans, the endometrium can be easily infected with bacteria, which may result in severe uterine diseases (4). Trauma or infection may cause endometrial repair disorder if trauma or infection damages the basal lamina of endometrium (5). An endometrium that is too thin is one of the most common causes of infertility in the uterus, which may cause embryos not to grow in the endometrium (6). Treatment of a thin endometrium consists mainly of drug therapy, stimulation scrape therapy and intrauterine injection of granulocyte colony-stimulating factor (7,8). Although these multiple approaches to treatment are available, the overall curative outcome is poor, making this condition in reproductive medicine challenging. Stem cells are undifferentiated cell populations with self-renewal and multilineage differentiation potential (9). Currently, the stem cells used for treatment of a thin endometrium include mesenchymal stem cells, human embryonic stem cells, endometrial stem cells and umbilical cord mesenchymal stem cells (10–13). In addition, successful repair of the endometrium in pregnancy with stem cells has been reported previously (14). A recent study demonstrated that the basal layer of the endometrium has high proliferative, self-renewal and differentiation potential of stem cells (15). Endometrial stem cells have been demonstrated to be ideal seed cells for the treatment of infertility caused by endometrial damage (16). However, direct access to endometrial stem cells is a process that may incur great damage. At present, the majority of endometrial stem cells are derived from the endometrium in patients undergoing hysterectomy (17), which means the source is limited. One study demonstrated that cast-off cells in endometrium isolated from menstrual blood may be cultured in vitro into becoming endometrial mesenchymal stem cells, and using this method, cells may proliferate at an increased rate (18). At the same time, because menstrual blood is considered human waste, investigators were able to avoid the problem of sensitive medical ethical issues. The use of menstrual blood-derived stem cell (MenSC) transplantation for repair of the endometrial injury in nude mice with endometrial injury has been previously investigated (19). In the present study, density gradient centrifugation was used to isolate MenSCs. In addition, a model of endometrial injury in nude mice was established for subsequent exploration of the effects of MenSCs on the repair of endometrial injury. These data may provide a novel strategy for the clinical treatment of endometrial injuries in humans.

Materials and methods

Ethical statement

The present study was approved by the Ethics Committee of the First Affiliated Hospital of Nanchang University (Nanchang, China), and all participants provided written informed consent prior to enrolment in the study. Animal experiments and animal use were approved by the Ethical Committee of Animal experiments of the Second Affiliated Hospital of Nanchang University (Nanchang, China). The animal experiments followed published guidelines (20) for the conservation and application of laboratory animals; all efforts were made to minimize suffering.

Culture and identification of MenSCs

Between March 2016 and March 2017, menstrual blood was collected from 10 healthy women volunteers (age, 20–35 years). The volunteers had regular menstruation, with a menstrual cycle of 24–35 days (average, 28 days) and no medical complications. Cells extracted from menstrual blood were placed in PBS. Briefly, mononuclear cells of menstrual blood were separated by the method of density gradient centrifugation at 400 × g for 15 min at room temperature with lymphocyte stratified liquid (GE Healthcare Life Sciences, Little Chalfont, UK) (21). Cells from the middle layer were extracted, washed with PBS, and the supernatant was then removed. Subsequently, cells were obtained via centrifugation at 400 × g at room temperature for 5 min and then resuspended in Dulbecco's modified Eagle's medium (DMEM)/Ham's F-12 (cat. no. 12634; Gibco; Thermo Fisher Scientific, Inc., Waltham, MA, USA) supplemented with 10% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.), mixed evenly, counted and adjusted to an appropriate density (1×106 cells/ml) for cell culture. The cells were inoculated into DMEM high-glucose medium (Hyclone; GE Healthcare Life Sciences, Logan, UT, USA) containing 20% fetal bovine serum (Gibco; Thermo Fisher Scientific, Inc.), 1% amphotericin B and 1% mycillin (Gibco; Thermo Fisher Scientific, Inc.) for incubation. Following culturing for 72 h at 37°C, the culture medium was changed every 3 days. When cell confluence reached 90%, cell passage was conducted. Cells at the third generation were selected, re-suspended in PBS and placed into a 2 ml Eppendorf tube (2×105 cells). Cells were placed in an ice bath, fluorescent labelled- associated antibodies (2 µl each) phycoerythrin-cyanine 5-conjugated cluster of differentiation (CD)90 (CD90-PE/Cy5; 1:1,000; cat. no. ab25272; Abcam, Cambridge, MA, USA) and fluorescein isothiocyanate (FITC)-conjugated CD146 (CD146-FITC; 1:1,000; cat. no. ab78451; Abcam, Cambridge, MA, USA) were added to each tube and incubated at 4°C for 1 h. Subsequently, cells were resuspended in PBS (20 µl). Flow cytometry and FlowJo software version 6.1 (Tree Star, Inc., Ashland, OR, USA) was used to detect the expression of surface markers to identify MenSCs.

Adenovirus-enhanced green fluorescent protein (Ad-eGFP) transfection

Isolated MenSCs (1×107 cells/ml) were seeded into a six-well plate, and Ad-eGFP [2×108 particle-forming units (PFU); final concentration, 1×108 PFU/ml] was added to each well. Following transfection for 24 h, MenSCs were observed under a fluorescence microscope. The MenSCs were digested by trypsin, and the transfection rate was detected by flow cytometry using FlowJo software version 6.1 (Tree Star, Inc.). Briefly, MenSCs were digested by 2.5 ml/l trypsin, centrifuged at 1,000 × g at room temperature for 3 min and then collected into a 1.5 ml Eppendorf tube. Following this, DMEM/F12 medium (Gibco; Thermo Fisher Scientific, Inc.) was added to the tube to reach a volume of 200 µl, and cell suspension density was adjusted to 1×107 cells/ml. Following MenSC transplantation into the uterine cavity of model mice, levels of green fluorescence were determined with a BX53 fluorescence microscope (Olympus Corporation, Tokyo, Japan).

Establishment of a mechanical damage model of unilateral endometrium in BALB/c nude mice

A total of 109 BALB/c female nude mice (age, 10–12 weeks; weight, 17.5–20.5 g) purchased from Hunan SJA Laboratory Animal Co., Ltd. (Changsha, China) were used in this study, of which 79 mice were randomly selected and anaesthetized by intraperitoneal injection of 1% pentobarbital sodium (0.75 ml/10 g). Mice were housed at a temperature of 22–24°C, a humidity of 45–70%, a 12/12 h light/dark cycle, and with free access to food and water. When the mice had no limb reaction, they were placed in a supine position with the limbs fixed on the operating table with aseptic pads. The operation area was disinfected by 75% alcohol, and a longitudinal incision of 1.5 cm was made at the top of the bladder in the midline abdomen. Ophthalmic forceps were used to lift the skin, and ophthalmic scissors were used to cut the skin layer-by-layer longitudinally. In the back of the bladder, the bilateral uterus was touched, straight forceps were used to clamp the fallopian tubes with the cornu uteri (bilateral uterine horns) exposed. An incision was made in the right uterine horn, and a 4-gauge needle was inserted at a location 2/3 of the distance between the cornu uteri and the corpus uterus and rotated to scratch the area 4 times. Subsequently, streptomycin (100 mg/ml) was used at the incision, and the muscles and skin were sutured layer-by-layer. Mechanical damage of the endometrium was established in the right uterus (Model group), whereas the left uterus was not treated (Normal group). Following suture, nursing care at 37°C was conducted to ensure recovery within 2 h. Following rearing, 3 mice were sacrificed by cervical dislocation at days 1, 3 and 5, and the bilateral uterine horns exposed. The cornu uteri were fixed in 4% paraformaldehyde for >24 h, embedded in paraffin, and sectioned to a thickness of 4 µm. The sections were stained with hematoxylin and eosin (H&E), as described below, and light microscopy was used to observe the conditions of the mechanically damaged endometrium model.

Green fluorescence detection following MenSC transplantation into the uterine cavity of Model mice

From the 70 remaining model mice, 10 mice with specific-pathogen-free conditions were used in the present study. The MenSC cell suspension (1×107 cells/ml; 20 µl) was injected into the right uterine cavity of 10 mechanically damaged Model mice, and the left uterine cavity was injected with equivalent PBS for use as the control. A total of 5 days post-injection, the mice were sacrificed, the abdominal cavity was opened and the uterine horns collected. Subsequently, the uterine horns were incubated with 4% paraformaldehyde for 24 h at room temperature and then dehydrated overnight in 20% sucrose at 4°C. Following this, tissues were embedded in optimal cutting temperature compound (Sakura Finetek USA, Inc., Torrance, CA, USA) for 10–15 min at −20°C and then sliced using a frozen section preparation instrument Cryostat (Leica Microsystems, Inc., Buffalo Grove, IL, USA) to establish frozen sections (10 µm). Sections were then examined under a fluorescent electron microscope (magnification, ×100).

Animal grouping

From the 60 remaining model mice, 30 mice were randomly selected and injected with a 20 µl MenSC suspension (1×107 cells/ml) into the damaged right uterine cavity (MenSC group), and 30 model mice were injected with equivalent PBS into the right uterine cavity (Model group). In addition, another 30 mice with undamaged right uterine horns were injected with 20 µl MenSCs suspension into the right uterine cavity [negative control (NC) group]. The untreated left uteri of all groups was not injected with MenSCs or PBS and used as the Normal group (n=90; n=30 per group). Following treatment, three mice from each group were sacrificed at days 1, 3 and 5. The uterus was dissected and bilateral uterine tissue was resected. The tissues were dehydrated in an increasing gradient of alcohol, cleared in xylene, embedded in paraffin wax, sectioned (4 µm) and prepared for follow-up H&E staining, as described below. At day 7 post-treatment, 21 mice in each group were randomly selected for fertility testing: Female mice (3 oestrus cycles; aged 11–13 weeks old; weight, 18.2–29.5 g) were placed in a cage with the same strain male mice (one female and male mouse per cage housed under the aforementioned conditions), which were purchased from Hunan SJA Laboratory Animal Co., Ltd (Changsha, China) and the pregnancy rate of mice in each group was observed.

H&E staining

H&E-stained sections were used to observe the level of damage to the endometrium. Paraffin wax in the sections was removed by xylene and sections were washed with high to low concentrations of alcohol (100 alcohol, 95 alcohol, 80 alcohol and 70% alcohol) and distilled water for 3 min, stained in haematoxylin for 3 min, washed in running water 3 times, dehydrated with alcohol for 10 min, stained with eosin, cleaned with xylene and mounted with resinene (Sigma-Aldrich; Merck KGaA, Darmstadt, Germany). Subsequently, the sections were observed under a light microscope (Olympus Corporation, Tokyo, Japan) and five different visual fields were photographed and examined per slide.

Immunohistochemistry (IHC) and average endometrial thickness measurement

Five days following grouping, sections were selected, dewaxed and rehydrated according to the aforementioned protocol and each slice was then supplemented with 50 µl peroxidase blocking solution (Sigma-Aldrich; Merck KGaA) and incubated for 10 min at room temperature to block endogenous peroxidase activity. Following rinsing with PBS, the PBS solution was removed and the endometrial sections were incubated with 50 µl of normal non-immune animal serum (Sigma-Aldrich; Merck KGaA) for 10 min at room temperature to remove serum. Subsequently, primary antibodies against vimentin (1:200; cat. no. ab92547; Abcam, Cambridge, UK), vascular endothelial growth factor (VEGF; 1:100; cat. no. ab9546; Abcam) and keratin (1:200; cat. no. ab8068; Abcam) were added to the sections and incubated at 4°C overnight. The sections were placed at room temperature for 1 h, washed three times with PBS, 10 min each. Sheep anti-rabbit IgG antibodies (1:1,000; cat. no. ab6795; Abcam) were added to the sections and incubated at room temperature for 2 h. Following treatment with 3,3′-Diaminobenzidine at 37°C for 5 min, the sections were washed in PBS and counterstained with 5% hematoxylin solution (Beyotime Institute of Biotechnology, Haimen, China) for 3 min at room temperature. Following development, sections were photographed using a light microscope (magnification, ×400; Olympus Corporation), and five different visual fields were analysed. Image-Pro Plus 6 processing software (Media Cybernetics, Inc., Rockville, MD, USA) was used to analyse results and to calculate average optical density (AOD); AOD=integrated OD/measurement area. The higher the AOD is, the higher the expression of the protein. Magnification at ×400 was also used to measure the average endometrial thickness.

Statistical analysis

Statistical analysis was conducted with SPSS 21.0 (IBM Corp., Armonk, NY, USA). Enumeration data were presented by percentage and tested by χ2, whereas measurement data were presented as the mean ± standard deviation. Comparisons between two groups were conducted by unpaired Student's t-test, and comparisons among multiple groups were analysed using one-way analysis of variance followed by Bonferroni correction. P<0.05 was considered to indicate a statistically significant difference.

Results

Cultured menstrual blood cells have stem cell characteristics

Following the culture of MenSCs for 24 h, tadpole and polygonal adherent cells were observed under a microscope (Fig. 1A). Following 72 h, the whole medium was replaced, and impure cells were removed. Following culturing for 3–4 days, cells were not of uniform size and presented as a colony growth with uneven distribution. Following culturing for seven days, a small number of polygonal cells were observed, and most cells were clearly fusiform with rich and transparent cytoplasm and oval and cantered nuclei; in addition, cells grew in adherence to a non-polar arrangement (Fig. 1A). Flow cytometric analysis of cells at the third generation demonstrated that CD90-PE-positive cells accounted for 96.2% and CD146-FITC-positive cells accounted for 0.014% (Fig. 1B and C, respectively), which indicated a high expression of the haematopoietic stem cell marker CD90 and low expression of mesenchymal stem cell marker CD146. These results demonstrated that the cultured cells exhibited stem cell characteristics.
Figure 1.

Culture and identification of MenSCs. (A) Morphological observation of MenSCs at different time points: Left panel, cell morphology at the 24 h time interval (magnification, ×100); middle panel, cell morphology at the 72 h time interval (magnification, ×100); right panel, cell morphology at the 7 day time interval (magnification, ×100). (B and C) MenSCs examined by flow cytometry exhibited (B) high CD90-PE expression and (C) low CD146-FITC expression. CD, cluster of differentiation; FITC, fluorescein isothiocyanate; MenSCs, menstrual blood-derived stem cells; PE, phycoerythrin.

Successful establishment of a mechanically damaged endometrium model in mice

The unilateral injury model of nude mice was established via mechanical injury, and following modelling for 1, 3, and 5 days, the uteri were collected and stained with H&E. Detached endometrial tissue was observed in the Model group at the 1 day time interval, fibrosis was observed in the endometrium of the Model group at the 3 day time interval, and no normal endometrium was observed while fibrosis was observed in the endometrium of the Model group at the 5 day time interval; whereas no fibrosis was detected in the Normal group (Fig. 2). These results indicated that the endometrial mechanical damage model was successfully established.
Figure 2.

Examination of endometrium in Model mice. Right uterine horns were collected from Model mice and examined for fibrosis by haematoxylin and eosin staining at days 1, 3 and 5 following endometrial damage; the left uterine horns were undamaged and used as a Normal control. Black arrow indicates endometrial fibrosis. Magnification, ×100.

MenSCs grow in the endometrium of model mice

Following transfection for 24 h, Ad-eGFP-MenSCs were observed under a fluorescence microscope, and the transfection rate was up to 48.5% (Fig. 3A and B). Ad-eGFP-MenSCs were transplanted into the right uterus of model mice (MenSC group), and PBS was injected into the Model group mice; in the MenSC-treated model mice, green fluorescence was detected in the endometrium (Fig. 3C), which suggested that the MenSCs were able to grow in the endometrium of nude mice.
Figure 3.

Ad-eGFP-transfected MenSCs are able to grow in nude mice. (A and B) MenSCs were transfected with Ad-eGFP and (A) observed under a fluorescence microscope and (B) the number of positive (green) cells were quantified by flow cytometry at 24 h following transfection. (C) Ad-eGFP-transfected MenSCs were transplanted into the right uterine horn of endometrial damaged model mice and endometrial sections were observed under a fluorescence microscope; Model control mice received endometrial damage and treated with PBS. Ad-eGFP, adenovirus-enhanced green fluorescent protein; MenSCs, menstrual blood-derived stem cells.

MenSC treatment increases endometrial thickness and promotes endometrial repair

At 5 days post-treatment, the results of IHC demonstrated that the endometrial thickness of the Model group was thinner compared with the Normal group (P<0.05; Fig. 4); the endometrial thickness of mice in the MenSC group was increased compared with mice in the untreated Model group, but no significant difference was identified (P>0.05). In addition, the endometrial thickness of the MenSC group was significantly decreased compared with normal group (P<0.05; Fig. 4). Compared with the NC group, the endometrial thickness of Model and MenSC groups were significantly decreased (P<0.05; Fig. 4). No significant difference was detected in a comparison of the endometrial thickness between the Normal and NC groups (P>0.05; Fig. 4). These results revealed that endometrial thickness decreased following endometrial damage, and this effect may be reversed following MenSC treatment in model mice.
Figure 4.

MenSCs treatment affects the thickness of the damaged endometrium in Model mice. (A) Immunohistochemical staining of the endometrium from mice from each group; magnification, ×40. (B) Quantification of the endometrial thickness in mice from each group. *P<0.05 vs. Normal. #P<0.05 vs. NC. MenSCs, menstrual blood-derived stem cells; NC, negative control.

MenSCs promote the repair of endometrium by promoting the expression of vimentin, VEGF and keratin

Keratin is expressed in epithelial cells, which are associated with epithelial growth (22). Vimentin is mainly expressed in mesenchymal cells and endothelial cells, which are associated with stromal cell regrowth (22). VEGF is associated with angiogenesis (23). Thus, keratin, vimentin and VEGF are associated with endometrial repair. At 5 days post-treatment, the results of IHC demonstrated that positive staining of vimentin, VEGF and keratin was brown or tan (Fig. 5). No significant difference was detected in the AOD of vimentin, VEGF and keratin between the Normal and NC groups (P>0.05). The AOD of vimentin, VEGF and keratin in the Model group was significantly lower compared with the respective expression levels in the Normal and NC groups (P<0.05). The AOD of vimentin, VEGF and keratin in the MenSC group were significantly higher compared with the respective expression levels in the untreated Model group (P<0.05). These data indicated that MenSCs may promote the repair of endometrial lesions in model mice by promoting the expression of vimentin, VEGF and keratin.
Figure 5.

Expression of vimentin, VEGF and keratin proteins in the endometrium of Model mice. (A) Immunohistochemical staining of endometrium from mice in each group; magnification, ×400. (B) Quantification of the expression of vimentin, VEGF and keratin from Part A. *P<0.05 vs. Normal; #P<0.05 vs. Model. AOD, average optical density; MenSCs, menstrual blood-derived stem cells; NC, negative control; VEGF, vascular endothelial growth factor.

MenSCs increase the fertility of damaged endometrium in nude mice

Fertility tests demonstrated that the undamaged left uterus in mice from each group were successfully impregnated (42 out of 42; 100%; Table I). In the Model group, 4 pregnancies occurred out of 21 mice with right uterine horn damage (19.04%), whereas 11 out of 21 pregnancies occurred in the MenSC-treated group (52.38%), which was significantly higher compared with the untreated Model group (P<0.05). The results demonstrated that MenSC treatment may improve the fertility rates in Model mice with the damaged endometrium.
Table I.

Pregnancy rates of mice in each group.

Fertility statusNormal (n=21)[a]NC (n=21)[b]Model (n=21)[b]MenSC (n=21)[b]
Pregnancy2121411
Not pregnancy001710
Pregnancy rate (%)10010019.0452.38[c]

Normal group comprised the left uterine horns from the Control and MenSC group.

Right uterine horn only.

P<0.05 vs. Model. MenSC, menstrual blood-derived stem cell; NC, negative control.

Discussion

Good endometrial receptivity, which is indicated by endometrial thickness and blood flow, is an important condition for a successful pregnancy (24,25). Previous studies have demonstrated that the pregnancy rates of patients with endometrial thickness <7 mm was significantly decreased (24,25). Although there are several treatment strategies for a thin endometrium currently available, some patients receiving treatment still have a low response or none at all (26,27). The present study demonstrated that MenSCs could be isolated from menstrual blood and used to promote the repair of endometrial lesions in nude mice. A previous study reported that bone marrow mesenchymal stem cell transplantation could be used for the treatment of intrauterine adhesion syndrome (28). Another study demonstrated that MenSCs were able to differentiate into endometrial epithelial cells (29). Previous studies have also demonstrated that MenSCs exhibited positive expression of the haematopoietic stem cell marker CD90 and negative expression of the mesenchymal stem cell marker CD146 (30,31). Similarly, in the present study, MenSCs were isolated from healthy women and cultured in vitro; these cells exhibited stem cell-like characteristics with high CD90 expression and low CD46 expression. At present, mechanical and thermal injury are commonly used methods for establishing a model of endometrial injury (28,32). However, these models used normal immune mice, and the establishment of similar nude mouse models have not yet been reported. In the present study, a model of endometrial injury in nude mice was successfully constructed using the mechanical damage method by Alawadhi et al (28). Thin endometrium is characterized by slow growth of the glandular epithelium; therefore, the regeneration of epithelial cells is especially important for the improvement of the thin endometrium (33). MenSCs transfected with Ad-eGFP were able to grow in the endometrium of nude mice. It was demonstrated that endometrial thickness decreased following endometrial damage, while MenSCs treatment increased endometrial thickness, promoted endometrial repair and increased the fertility of damaged endometrium in nude mice. These results were similar to a previous study, which demonstrated that MenSCs were able to repair injured endometrium and increase the fertility of mice suffering endometrial injury (34). Furthermore, the present study demonstrated that MenSC-treated model mice exhibited increased protein expression levels of vimentin, VEGF and keratin. Vimentin is a cytoskeletal protein that is mainly expressed in the cytoskeleton of mesenchymal cells and functions to maintain the stability of cell structure and is involved in mitosis, differentiation, proliferation and signal transduction (35). VEGF is a highly specific mitogen of vascular endothelial cells and is an important regulator of angiogenesis; its expression reflects the level of proliferation, migration and vascular construction of vascular endothelial cells (36,37). VEGF is expressed in the glandular epithelium and vascular endothelial cells of the thin and normal endometrium, and the expression of VEGF in the thin endometrium was lower (38). Another study demonstrated that icariin treatment increase the thin endometrium in a rat model of intimal thickness by upregulation of VEGF expression (39). Keratin is a protein marker of epithelial cells, which serves an important role in maintaining the integrity of epithelial cells (40). A previous study demonstrated increased expression of keratin in endometrial tissues (41). In agreement with the results of the present study, Zhu et al (19) demonstrated that MenSC-based therapies may represent promising methods for the treatment of endometrial injury via the regulation of AKT and p38 signalling pathways. In conclusion, the present study demonstrated that MenSCs could be isolated from the menstrual blood and were able to survive in the endometrium of nude mice with endometrial damage. Furthermore, MenSCs were able to improve the embryo implantation rate, possibly by promoting the expression levels of vimentin, keratin and VEGF. Additional experiments are required to explore the possible molecular mechanisms underlying the association between MenSCs and endometrial fibrosis.
  39 in total

Review 1.  Keratins in health and cancer: more than mere epithelial cell markers.

Authors:  V Karantza
Journal:  Oncogene       Date:  2010-10-04       Impact factor: 9.867

2.  Spatial and temporal characterization of endometrial mesenchymal stem-like cells activity during the menstrual cycle.

Authors:  Shan Xu; Rachel W S Chan; Ernest H Y Ng; William S B Yeung
Journal:  Exp Cell Res       Date:  2016-11-24       Impact factor: 3.905

Review 3.  Identification and Characterization of Human Endometrial Mesenchymal Stem/Stromal Cells and Their Potential for Cellular Therapy.

Authors:  Saeedeh Darzi; Jerome A Werkmeister; James A Deane; Caroline E Gargett
Journal:  Stem Cells Transl Med       Date:  2016-05-31       Impact factor: 6.940

4.  [Co-culture with endometrial stromal cells promotes the differentiation of menstrual blood-derived mesenchymal stem cells into endometrial epithelial cells].

Authors:  Y S Jiang; H Y Zhu; X Y Jin; C Li; J Li; Y L Zhang; S Y Zhang
Journal:  Zhonghua Yi Xue Za Zhi       Date:  2017-09-05

5.  Effect of pentoxifylline on vascular endothelial growth factor C and flk-1 expression on endometrial implants in the rat endometriosis model.

Authors:  Nikos F Vlahos; Odysseas Gregoriou; Aikaterini Deliveliotou; Despoina Perrea; Athanasios Vlachos; Yulian Zhao; Joseph Lai; George Creatsas
Journal:  Fertil Steril       Date:  2009-01-14       Impact factor: 7.329

6.  Granulocyte-colony stimulating factor as treatment option in patients with recurrent miscarriage.

Authors:  Claudia Santjohanser; Catherine Knieper; Cordula Franz; Kaino Hirv; Osama Meri; Manfred Schleyer; Wolfgang Würfel; Bettina Toth
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-01-24       Impact factor: 4.291

7.  Bone marrow-derived cells from male donors can compose endometrial glands in female transplant recipients.

Authors:  Tomomi Ikoma; Satoru Kyo; Yoshiko Maida; Satoru Ozaki; Masahiro Takakura; Shinji Nakao; Masaki Inoue
Journal:  Am J Obstet Gynecol       Date:  2009-10-03       Impact factor: 8.661

8.  Pathophysiologic features of "thin" endometrium.

Authors:  Ichiro Miwa; Hiroshi Tamura; Akihisa Takasaki; Yoshiaki Yamagata; Katsunori Shimamura; Norihiro Sugino
Journal:  Fertil Steril       Date:  2008-03-06       Impact factor: 7.329

9.  Growth Kinetics, Characterization, and Plasticity of Human Menstrual Blood Stem Cells.

Authors:  Davood Mehrabani; Roshanak Bahrami Nazarabadi; Maryam Kasraeian; Amin Tamadon; Mehdi Dianatpour; Akbar Vahdati; Shahrokh Zare; Farnaz Ghobadi
Journal:  Iran J Med Sci       Date:  2016-03

10.  Epithelial cell migration requires the interaction between the vimentin and keratin intermediate filaments.

Authors:  Cristina Velez-delValle; Meytha Marsch-Moreno; Federico Castro-Muñozledo; Ivan J Galván-Mendoza; Walid Kuri-Harcuch
Journal:  Sci Rep       Date:  2016-04-13       Impact factor: 4.379

View more
  13 in total

Review 1.  Looking beyond the ovary for oncofertility care in women: uterine injury as a potential target for fertility-preserving treatments.

Authors:  D Garg; E B Johnstone; L Lomo; D B Fair; M P Rosen; R Taylor; B Silver; J M Letourneau
Journal:  J Assist Reprod Genet       Date:  2020-04-28       Impact factor: 3.412

Review 2.  The Role of Endometrial Stem/Progenitor Cells in Recurrent Reproductive Failure.

Authors:  Hannan Al-Lamee; Christopher J Hill; Florence Turner; Thuan Phan; Andrew J Drakeley; Dharani K Hapangama; Nicola Tempest
Journal:  J Pers Med       Date:  2022-05-11

3.  Development and Validation of a Prognostic Classifier Based on Lipid Metabolism-Related Genes for Breast Cancer.

Authors:  Nan Wang; Yuanting Gu; Lin Li; Jiangrui Chi; Xinwei Liu; Youyi Xiong; Chaochao Zhong
Journal:  J Inflamm Res       Date:  2022-06-14

Review 4.  Mesenchymal stem cells for restoring endometrial function: An infertility perspective.

Authors:  Ruttachuk Rungsiwiwut; Pramuan Virutamasen; Kamthorn Pruksananonda
Journal:  Reprod Med Biol       Date:  2020-07-20

5.  Effect of Autologous Adipose-Derived Stromal Vascular Fraction Transplantation on Endometrial Regeneration in Patients of Asherman's Syndrome: a Pilot Study.

Authors:  Se Yun Lee; Ji Eun Shin; Hwang Kwon; Dong Hee Choi; Ji Hyang Kim
Journal:  Reprod Sci       Date:  2020-01-01       Impact factor: 3.060

Review 6.  Stem Cell-Based Therapy for Asherman Syndrome: Promises and Challenges.

Authors:  Yiyin Gao; Guijie Wu; Ying Xu; Donghai Zhao; Lianwen Zheng
Journal:  Cell Transplant       Date:  2021 Jan-Dec       Impact factor: 4.064

7.  Effect of sildenafil citrate on treatment of infertility in women with a thin endometrium: a systematic review and meta-analysis.

Authors:  Xin Li; Ting Luan; Chun Zhao; Mianqiu Zhang; Li Dong; Yan Su; Xiufeng Ling
Journal:  J Int Med Res       Date:  2020-11       Impact factor: 1.671

8.  Transplantation of Human Adipose Stem Cells Using Acellular Human Amniotic Membrane Improves Angiogenesis in Injured Endometrial Tissue in a Rat Intrauterine Adhesion Model.

Authors:  Xiao Han; Yuejiao Ma; Xin Lu; Weihong Li; Enlan Xia; Tin-Chiu Li; Haiyan Zhang; Xiaowu Huang
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

Review 9.  Stem Cells and the Endometrium: From the Discovery of Adult Stem Cells to Pre-Clinical Models.

Authors:  Lucía de Miguel-Gómez; Sara López-Martínez; Emilio Francés-Herrero; Adolfo Rodríguez-Eguren; Antonio Pellicer; Irene Cervelló
Journal:  Cells       Date:  2021-03-08       Impact factor: 6.600

Review 10.  Making More Womb: Clinical Perspectives Supporting the Development and Utilization of Mesenchymal Stem Cell Therapy for Endometrial Regeneration and Infertility.

Authors:  Michael Strug; Lusine Aghajanova
Journal:  J Pers Med       Date:  2021-12-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.